Colorectal cancer and gut microbiota studies in China.
Wang Z, Dan W, Zhang N, Fang J, Yang Y.
Gut Microbes. 2023 Jan-Dec;15(1):2236364. doi: 10.1080/19490976.2023.2236364.
PMID:37482657
Mucosal microbiome dysbiosis in gastric carcinogenesis.
Coker OO, Dai Z, Nie Y, Zhao G, Cao L, Nakatsu G, Wu WK, Wong SH, Chen Z, Sung JJY, Yu J.
Gut. 2018 Jun;67(6):1024-1032. doi: 10.1136/gutjnl-2017-314281. Epub 2017 Aug 1.
PMID:28765474
Parvimonas micra activates the Ras/ERK/c-Fos pathway by upregulating miR-218-5p to promote colorectal cancer progression.
Chang Y, Huang Z, Hou F, Liu Y, Wang L, Wang Z, Sun Y, Pan Z, Tan Y, Ding L, Gao H, Yang R, Bi Y.
J Exp Clin Cancer Res. 2023 Jan 10;42(1):13. doi: 10.1186/s13046-022-02572-2.
PMID:36627634
Parvimonas micra, an oral pathobiont associated with colorectal cancer, epigenetically reprograms human colonocytes.
Bergsten E, Mestivier D, Donnadieu F, Pedron T, Barau C, Meda LT, Mettouchi A, Lemichez E, Gorgette O, Chamaillard M, Vaysse A, Volant S, Doukani A, Sansonetti PJ, Sobhani I, Nigro G.
Gut Microbes. 2023 Dec;15(2):2265138. doi: 10.1080/19490976.2023.2265138. Epub 2023 Oct 16.
PMID:37842920
Infection Route of Parvimonas micra: A Case Report and Systematic Review.